IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Revance Therapeutics Inc 144A

Q3 2020 vs Q4 2020

Comparing institutional holders between quarters

Quarters

Q4 2020Q3 2020Q2 2020Q1 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Kornitzer Capital Management Inc
INCREASED
Shares3,000,000 from 2,500,000
Change+500,000 (+20%)
Value$3.4K (+$730)
Filed 2021-01-29
Status
Kornitzer Capital Management Inc
INCREASED3,000,0002,500,000+500,000+20%$2.6K$3.4K+$7302021-01-29
Showing 1 of 1 institutions